In addition, patients with a higher BCMA expression on CLL cells had a shorter PFS compared with patients with lower BCMA expression (median, 57 months vs. 206 months; p = 0.021). The gene discussed is TNFRSF17; the disease is B-cell chronic lymphocytic leukemia.